A Study on Susceptibility Pattern of Nitrofurantoin in Clinical Isolates of Enterococcus
A Study on Susceptibility Pattern of Nitrofurantoin in Clinical Isolates of Enterococcus
DOI:
https://doi.org/10.70284/njirm.v8i3.1244Keywords:
Enterococci, Antibiotic susceptibility testing, NitrofurantoinAbstract
Introduction: Recent years have witnessed a resurgence of interest in enterococci due to increasing resistance to antibiotics in term of both multiplicity of resistance & level of resistance to particular drugs. In such scenario nitrofurantoin may be the effective option specially in case of urinary tract infection cause by enterococcus. Methodology: This is a hospital based study, conducted in Microbiology Department of an medical college in M.P. Antibiotic susceptibility performed on enterococci isolated from urine samples in the study period of one and half year Result: Enterococcal species isolated mainly E.faecalis (86.62%) and E.faecium (15.18%). In Enterococcus, 89.4% isolates showed resistance to Penicillin, 58.8% to Ampicillin, 61.1% to High Level Gentamicin (HLG) and 54.1% to High Level Streptomycin (HLS) Nitrofurantoin (24.7%), Ciprofloxacin (61.2%), Levofloxacin (63.5%), Norfloxacin (64.7%), Tetracycline (54.1%). Discussion: Our study showed that only 40% E.faecalis and 10% of E.faecium were resistant to nitrofurantoin. Similar result published from Nagpur by Rahangdale et al. According to them enterococci showed only 22.76 % resistant to nitrofurantoin. Conclusion: Enterococcus show very good susceptibility for nitrofurantoin as compare to other commonly use antibiotic for treatment of enterococcal infection. [Saurabh J NJIRM 2017; 8(3):53-56]
References
2. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant Enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-9.
3. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in Enterococci. Antimicrob. Agents. Chemother. 37:1563-1571
4. Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001;61:353-6
5. McOsker CC, Fitzpatrick PM. Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994;33 Suppl A: 23-30.
6. Komp Lindgren P, Klockars O, Malmberg C, Cars O. Pharmacodynamic studies of nitrofurantoin against common uropathogens. J Antimicrob Chemother 2015;70:1076-82.
7. Munoz-Davila MJ. Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of loweer urinary tract infections. Antibiotics 2014;3:39-48.
8. Duff P. Antibiotic selection in obstetrics: Making cost-effective choices. Clin Obstet Gynecol 2002;45:59-72.
9. Oplinger M, Andrews CO. Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: Looking for the evidence. Ann Pharmacother 2013;47:106-11.
10. Color Atlas and textbook of Microbiology by Koneman. 5th edition page 597-599.
11. Manual of clinical microbiology, editor in chief, Patrick R., Murray, editors, Eiien Jo Baron et al 9th ed. 2007, Vol II, 430-442
12. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493-6.
13. Seema Bose*1, Atindra Krishna Ghosh2, Rekha Barapatre3. Prevalence Of Drug Resistance Among Enterococcus Spp Isolated From A Tertiary Care Hospital. Int J Med Health Sci. July 2012,Vol-1;Issue-3.
14. DK Mendiratta, H Kaur, V Deotale, DC Thamke, R Narang, P Narang. Status of high level aminoglycoside resistant entericoccus faecium & enterococcus faecalis in a rural hospital of central India. Indian Journal of Medical Microbiology, (2008) 26(4): 369-71
15. 15. VA Agarwal, YI Jain, AA Pathak. Concomitant high level resistance to penicillin and aminoglycosides in enterococci at Nagpur, Central India. Indian J Med Microbiol Year : 1999 Volume : 17,Issue : 2, Page : 85-87.
16. Luna Adhikari. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Global Infect Dis 2010;2:231-235.
17. Jyotsna Agrawal*, Rajkumar Kalyan, and Mastan singh. High level aminoglycoside resistance and β-lactamase production in enterococci at a tertiary care hospital in india. Jpn. J. Infect. Dis.,62, 158-159, 2009.
18. VA Rahangdale, G Agrawal, SV Jalgaonkar. Study of antimicrobial resistance in enterococci. Indian J Med Microbiol Year : 2008, Volume : 26, Issue : 3 Page : 285-287.
19. M.G. Karmarkar, Edwin S. Gershom & P. R. Mehta. Enterococcal infections with special reference to phenotypic characterization & drug resistance. Indian J Med Res 119 (Suppl) May 2004, pp 22-25.
20. Ricardo Titze-de-Almeida1,4 et al. Molecular Epidemiology and Antimicrobial Susceptibility of Enterococci Recovered from Brazilian Intensive Care Units. The Brazilian Journal of Infectious Diseases 2004;8(3):197-205.
21. MM Salem-Bekhit1, IMI Moussa2, MM Muharram3, FK Alanazy4, HM Hefni5. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Indian J Med Microbiol Year : 2012 Volume : 30 Issue : 1 Page : 44-51
22. George G. Zhanel* Daryl J. Hoban, and James A. Karlowsky. Nitrofurantoin Is Active against Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy, Jan. 2001, p. 324–326).
